Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 2011. The report details a specific corporate action regarding the repurchase and cancellation of the company's ordinary shares, executed in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics and Capital Structure
The filing focuses on share repurchase activity rather than operational financial performance. Key metrics include:
- Shares Repurchased: 2,500,000 ordinary shares of 25 pence each.
- Repurchase Date: August 18, 2011.
- Price Range: Highest price paid was 1,282 pence per share; lowest price paid was 1,247.5 pence per share.
- Treasury Shares: Following cancellation, the Company holds 502,996,816 shares in Treasury.
- Treasury Ownership: Represents 9.00% of total issued share capital and 9.88% of total voting rights.
- Shares in Issue: 5,088,956,071 shares (excluding Treasury shares).
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the reduction of the Company's issued share capital through the cancellation of 2,500,000 repurchased shares. This action increased the proportion of Treasury shares held by the Company to 9.00% of total issued share capital.
Outlook, Risks, and Management Commentary
Management commentary is limited to the confirmation of the share buyback execution and the resulting capital structure. The filing explicitly states it does not constitute an offer or solicitation to purchase securities. No specific guidance, future outlook, risks, or contingencies are disclosed in this document.
Investor Verification Checklist
- Verify the total number of shares in issue (5,088,956,071) for calculating disclosure thresholds under Financial Services Authority rules.
- Confirm the updated Treasury share count (502,996,816) and its impact on voting rights (9.88%).
- Review the price paid per share (1,247.5 to 1,282 pence) against market prices on August 18, 2011.
- Check subsequent filings for operational financial results, as this 6-K contains no revenue or earnings data.